Abstract:An ever growing number of reports on graft rejection and/or failure even with good HLA matches have highlighted an important role of non-HLA antigens in influencing allograft immunity. The list of non-HLA antigens that have been implicated in graft rejection in different types of organ transplantation has already grown long. Of these, the Major Histocompatibility Complex class I chain-related molecule A (MICA) is one of the most polymorphic and extensively studied non-HLA antigenic targets especially in the kidney transplantation. Humoral response to MICA antigens has repeatedly been associated with lower graft survival and an increased risk of acute and chronic rejection following kidney and liver transplantation with few studies showing conflicting results. Although there are clear indications of MICA antibodies being associated with adverse graft outcome, a definitive consensus on this relationship has not been arrived yet. Furthermore, only a few studies have dealt with the impact of MICA donor-specific antibodies as compared to those that are not donor specific on graft outcome. In addition to the membrane bound form, a soluble isoform of MICA (sMICA), which has the potential to engage the natural killer cell-activating receptor NKG2D resulting in endocytosis and degradation of receptor-ligand interaction complex leading to suppression of NKG2D-mediated host innate immunity, has been a subject of intense discussion. Most studies on sMICA have been directed toward understanding their influence on tumor growth, with limited literature focusing its role in transplant biology. Furthermore, a unique dimorphism (methionine to valine) at position 129 in the α2 domain categorizes MICA alleles into strong (MICA-129 met) and weak (MICA-129 val) binders of NKG2D receptor depending on whether they have methionine or valine at this position. Although the implications of MICA 129 dimorphism have been highlighted in hematopoietic stem cell transplantation, its role in solid organ transplantation is yet to be explored. This review summarizes the currently available information on MICA antibodies, soluble MICA, and MICA-129 dimorphism in a setting of solid organ transplantation.

Research progress on major histocompatibility complex class Ⅰ chain-related protein A-natural killer group 2 member D passageway in head and neck squamous cell carcinoma

The clinical and biological significance of MICA in clear cell renal cell carcinoma patients

Natural killer and cytotoxic T lymphocyte-mediated cytotoxicity enhanced by genetic overexpression of MHC class I chain-related protein A in oral squamous cell carcinoma: An experimental study in vivo

Natural killer group 2D‐major histocompatibility complex class I polypeptide‐related sequence A activation enhances natural killer cell‐mediated immunity against hepatocellular carcinoma: A review

Expression and function of the major histocompatibility complex (MHC) class I chain-related A (MICA)*010 in NK cell killing activity

The Opposite Effect of Mmica and Rmica on the Expression of NKG2D and the Influence on NK Cell Receptor Repertoire

Antitumor immune response of MHC class Ⅰ chain-related gene A modified oral squamous cell carcinoma vaccine:An experimental study in mice

Novel Role of Immune-Related Non-Coding RNAs As Potential Biomarkers Regulating Tumour Immunoresponse Via MICA/NKG2D Pathway

Diseases Association with the Polymorphic Major Histocompatibility Complex Class I Related Chain A: MICA Gene

A Bispecific Protein Rg7s-Mica Recruits Natural Killer Cells and Enhances NKG2D-mediated Immunosurveillance Against Hepatocellular Carcinoma

Clinico-pathological significance of MHC-I type chain-associated protein A expression in oral squamous cell carcinoma.

Natural killer cells: a future star for immunotherapy of head and neck squamous cell carcinoma

Major Histocompatibility Complex Class II Molecule in Non-Small Cell Lung Cancer Diagnosis, Prognosis and Treatment

Analysis of the expression of MICA on tumor cell lines of different histotypes and their sensitivity to NK cytotoxicity

Opposing Effects of Interferon-Alpha and Interferon-Gamma on the Expression of Major Histocompatibility Complex Class I Chain-Related A in Tumors.

Major Histocompatibility Complex Class I Chain-Related A (MICA) Molecules: Relevance in Solid Organ Transplantation

Upregulated mRNA expression of major histocompatibility complex class I chain-related gene A in colon and activated natural killer cells of Chinese patients with ulcerative colitis

The Inhibitory Effects of Synthetic Short Peptides, Mimicking MICA and Targeting at NKG2D Receptors, on Function of NK Cells

The Relationship Between the MICA/B Expression on Cancer Cell Lines and Their Sensitivity to NK Cell Cytotoxicity

Expression of natural killer cell stimulatory receptor NKG2D and its ligand MICA in Tibetan patients with gastric cancer at Qinghai plateau

The Role of Major Histocompatibility Complex Class I Chain-Related Gene A Antibodies in Organ Transplantation